In terms of completion of the entire trial, 29 participants were treated with a combined treatment of cagrilintide and semaglutide and treatment with semaglutide by itslef while 30 participants were treated with cagrilintide
For SG testing, mice were injected daily at 3pm for three days prior to the beginning of fiber photometry recordings with SG, and injections continued daily throughout testing, following the conclusion of the subjects fiber photometry recording session
Semaglutide Both tirzepatide and semaglutide are powerful tools, but they act slightly differently: Semaglutide A GLP-1 receptor agonist Weekly injection (brand names Ozempic for diabetes, Wegovy for weight loss) Helps many patients achieve 1015% weight loss with lifestyle support Tirzepatide Dual-action: mimics GLP-1 and GIP (another metabolic hormone) Weekly injection (brand names Mounjaro and Zepbound) Some clinical trials show average weight loss of 1520% or more Because tirzepatide acts on two hormone pathways, it may have enhanced benefits for blood sugar control and weight reduction
Genetic Predispositions: Certain genetic factors may predispose individuals to a higher risk of blood clots when taking Wegovy
Additional sessions can be started if you haven't reached your goal
This is consistent with the insulin-sensitizing mechanism